CVE-2024-9969

NewType WebEIP v3.0 - Reflected XSS

Description

NewType WebEIP v3.0 does not properly validate user input, allowing a remote attacker with regular privileges to insert JavaScript into specific parameters, resulting in a Reflected Cross-site Scripting (XSS) attack. The affected product is no longer maintained. It is recommended to upgrade to the new product.

Remediation

Solution:

  • The vendor has stated that WebEIP v3.0 has been released for over 15 years and is no longer supported or maintained. It is recommended to upgrade to the new WebEIP Pro product.

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.05%
Third-Party Advisory org.tw Third-Party Advisory org.tw
Affected: NewType WebEIP
Published at:
Updated at:

References

Link Tags
https://www.twcert.org.tw/tw/cp-132-8134-c476d-1.html third party advisory
https://www.twcert.org.tw/en/cp-139-8135-ce1e6-2.html third party advisory

Frequently Asked Questions

What is the severity of CVE-2024-9969?
CVE-2024-9969 has been scored as a medium severity vulnerability.
How to fix CVE-2024-9969?
To fix CVE-2024-9969: The vendor has stated that WebEIP v3.0 has been released for over 15 years and is no longer supported or maintained. It is recommended to upgrade to the new WebEIP Pro product.
Is CVE-2024-9969 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-9969 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-9969?
CVE-2024-9969 affects NewType WebEIP.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.